Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V98158 | ABBV-383 | ABBV-383 (ABBV-383) is a BCMA×CD3 bispecific T-cell engager (BiTE) that inhibits B-cell maturation protein activity (BCMA) and activates the T-cell surface glycoprotein CD3 complex. | |
![]() |
V106419 | Amtabafusp alfa | Amtabafusp alfa is a humanized IgG1?λ1 antibody directed against CD3E/CD4. | |
![]() |
V106373 | Anti-Rat TCR alpha/beta Antibody (R73) | Anti-rat TCR alpha/beta antibody (R73) is a mouse-derived IgG1, kappa antibody inhibitor directed against rat TCR alpha/beta. | |
![]() |
V106385 | Avitotamig | Avitotamig is a [H-γ1 _ L-κ-scFv heavy-κ]-dimer bispecific antibody targeting CD3E/CD33. | |
![]() |
V106412 | Ebribafusp alfa | Ebribafusp alfa is an IgG4κ chimeric antibody directed against CD3E. | |
![]() |
V106393 | Gocatamig | Gocatamig is a chimeric humanized antibody of the type (scFv-heavy-lamdba)-VH-VH' targeting CD3E/ALB/DLL3. | |
![]() |
V106398 | Linclatamig | Linclatamig is a humanized IgG1κ antibody targeting CD3E. | |
![]() |
V106399 | Mipletamig | Mipletamig is a humanized and humanized chimeric antibody against CD3E [(scFv-κ-heavy) G1-h-CH2-CH3 (scFv-heavy-κ)] type 2. | |
![]() |
V106402 | Obrixtamig | Obrixtamig is a chimeric human antibody of the type L-κ-G1-h-CH2-CH3_L-λ-G1-h-CH2-CH3 against CD3E/HEK. | |
![]() |
V106441 | Pasritamig | Pasritamig is a (H-γ1_L-κ)_scFvkh-G1(h-CH2-CH3) type bispecific antibody targeting KLK2/CD3E. | |
![]() |
V106447 | Surovatamig | Surovatamig is a (H-γ4_L-κ)_VH-G4(h-CH2-CH3) type bispecific antibody targeting CD3D/CD3E/CD19. | |
![]() |
V106450 | Trevotamig | Trevotamig is a H-γ1_L-κ-scFvhl dimer bispecific antibody targeting EPCAM/CD3E. | |
![]() |
V106410 | Zubotamig | Zubotamig is an Ig(G1-κ_G1-λ2) chimeric human antibody against CD3E/VTCN1. | |
![]() |
V51154 | Muromonab | 140608-64-6 | Muromonab is a monoclonal antibody (mAb) that can inhibit CD3 capture. |